BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: de Bortoli N, Tolone S, Frazzoni M, Martinucci I, Sgherri G, Albano E, Ceccarelli L, Stasi C, Bellini M, Savarino V, Savarino EV, Marchi S. Gastroesophageal reflux disease, functional dyspepsia and irritable bowel syndrome: common overlapping gastrointestinal disorders. Ann Gastroenterol 2018;31:639-48. [PMID: 30386113 DOI: 10.20524/aog.2018.0314] [Cited by in Crossref: 25] [Cited by in F6Publishing: 32] [Article Influence: 6.3] [Reference Citation Analysis]
Number Citing Articles
1 Tikhonova TA, Kozlova IV. Irritable bowel syndrome: extra- intestinal comorbidity, psychological, morphometric and genetic predictors of variants of the course of the disease. jour 2022. [DOI: 10.31146/1682-8658-ecg-199-3-5-14] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Ceulemans M, Jacobs I, Wauters L, Vanuytsel T. Immune Activation in Functional Dyspepsia: Bystander Becoming the Suspect. Front Neurosci 2022;16:831761. [DOI: 10.3389/fnins.2022.831761] [Reference Citation Analysis]
3 Aono S, Tomita T, Tozawa K, Morishita D, Nakai K, Okugawa T, Fukushima M, Oshima T, Fukui H, Miwa H. Epidemiology and Clinical Characteristics Based on the Rome III and IV Criteria of Japanese Patients with Functional Dyspepsia. J Clin Med 2022;11:2342. [PMID: 35566472 DOI: 10.3390/jcm11092342] [Reference Citation Analysis]
4 Kim J, Lee S, Rhew K. Association between Gastrointestinal Diseases and Migraine. Int J Environ Res Public Health 2022;19:4018. [PMID: 35409704 DOI: 10.3390/ijerph19074018] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Ivashkin VT, Shelygin YA, Baranskaya EK, Achkasov SI, Belous SS, Belousova EA, Beniashviili AG, Vasiliev SV, Grigoriev EG, Kostenko NV, Moskalev AI, Kashnikov VN, Loranskaya ID, Lyashenko OS, Poluektova EA, Rumyantsev VG, Timerbulatov VM, Chashkova EY, Shapina MV, Sheptulin AA, Shifrin OS, Zolnikova OY, Baranovsky AY, Korochanskaya NV, Mammaev SN, Alekseeva OP, Khlynov IB, Tsukanov VV, Alekseenko SA. Irritable bowel syndrome. Koloproktologiâ 2022;21:10-25. [DOI: 10.33878/2073-7556-2022-21-1-10-25] [Reference Citation Analysis]
6 Nizhevitch AA, Gimazetdinova RS, Tuygunov MM, Yakupova GM. Biliary dyskinesia in children with irritable bowel syndrome: overlap syndrome. The search for a modern approach to the treatment of abdominal pain syndrome. Ross vestn perinatol pediatr 2022;66:121-128. [DOI: 10.21508/1027-4065-2021-66-6-121-128] [Reference Citation Analysis]
7 Ivashkin VT, Maev IV, Shelygin YA, Baranskaya EK, Belous SS, Belousova EA, Beniashvili AG, Vasilyev SV, Veselov AV, Grigoryev EG, Kostenko NV, Kashnikov VN, Kulikovskiy VF, Loranskaya ID, Lyashenko OS, Poluektova EA, Rumyantsev VG, Timerbulatov VM, Fomenko OY, Khubezov DA, Chashkova EY, Chibisov GI, Shapina MV, Sheptulin AA, Shifrin OS, Trukhmanov AS, Alekseeva OP, Alekseenko SA, Baranovsky AY, Zolnikova OY, Korochanskaya NV, Mammayev SN, Khlynov IB, Tsukanov VV. Diagnosis and Treatment of Irritable Bowel Syndrome: Clinical Recommendations of the Russian Gastroenterological Association and Association of Coloproctologists of Russia. Rossijskij žurnal gastroènterologii, gepatologii, koloproktologii 2022;31:74-95. [DOI: 10.22416/1382-4376-2021-31-5-74-95] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 7.0] [Reference Citation Analysis]
8 Scarpignato C. Acid-Lowering Drugs for the Treatment of Gastro-esophageal Reflux Disease. Gastroesophageal Reflux in Children 2022. [DOI: 10.1007/978-3-030-99067-1_22] [Reference Citation Analysis]
9 Lai Y, Chen C, Bair M. Epidemiology, Clinical Features, and Prescribing Patterns of Irritable Bowel Syndrome in Taiwan. Front Pharmacol 2021;12. [DOI: 10.3389/fphar.2021.788795] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Lazebnik LB, Golovanova EV, Volel BA, Korochanskaya NV, Lyalyukova EA, Mokshina MV, Mekhtiev SN, Mekhtieva OA, Metsaeva ZV, Petelin DS, Simanenkov VI, Sitkin SI, Cheremushkin SV, Chernogorova MV, Khavkin АI. Functional gastrointestinal disorders. Overlap syndrome Clinical guidelines of the Russian Scientific Medical Society of Internal Medicine and Gastroenterological Scientific Society of Russia. jour 2021. [DOI: 10.31146/1682-8658-ecg-192-8-5-117] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
11 Melchior C, Fremaux S, Jouët P, Macaigne G, Raynaud JJ, Facon S, Iglicki F, Taes Y, Sabate JM. Perceived Gastrointestinal Symptoms and Association With Meals in a French Cohort of Patients With Irritable Bowel Syndrome. J Neurogastroenterol Motil 2021;27:574-80. [PMID: 34642277 DOI: 10.5056/jnm20201] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
12 Gaus OV, Livzan MA. “Gastrointestinal” comorbidity in irritable bowel syndrome. jour 2021;1:104-111. [DOI: 10.31146/1682-8658-ecg-190-6-104-111] [Reference Citation Analysis]
13 Wauters L, Dickman R, Drug V, Mulak A, Serra J, Enck P, Tack J, Accarino A, Barbara G, Bor S, Coffin B, Corsetti M, De Schepper H, Dumitrascu D, Farmer A, Gourcerol G, Hauser G, Hausken T, Karamanolis G, Keszthelyi D, Malagelada C, Milosavljevic T, Muris J, O'Morain C, Papathanasopoulos A, Pohl D, Rumyantseva D, Sarnelli G, Savarino E, Schol J, Sheptulin A, Smet A, Stengel A, Storonova O, Storr M, Törnblom H, Vanuytsel T, Velosa M, Waluga M, Zarate N, Zerbib F; ESNM FD Consensus Group. United European Gastroenterology (UEG) and European Society for Neurogastroenterology and Motility (ESNM) consensus on functional dyspepsia. United European Gastroenterol J 2021;9:307-31. [PMID: 33939891 DOI: 10.1002/ueg2.12061] [Cited by in Crossref: 19] [Cited by in F6Publishing: 24] [Article Influence: 19.0] [Reference Citation Analysis]
14 Lee SW, Chang CS. Impact of Overlapping Functional Gastrointestinal Disorders on the Quality of Life in Patients With Gastroesophageal Reflux Disease. J Neurogastroenterol Motil 2021;27:176-84. [PMID: 33795540 DOI: 10.5056/jnm19006] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
15 Gogheri T, Samavi SA, Najarpourian S. Structural relationship model of type D personality and depression with the mediating role of cognitive distortions and family functioning in irritable bowel syndrome patients and healthy people: A multi-group analysis. Curr Psychol 2021. [DOI: 10.1007/s12144-021-01755-y] [Reference Citation Analysis]
16 Duncanson K, Burns G, Pryor J, Keely S, Talley NJ. Mechanisms of Food-Induced Symptom Induction and Dietary Management in Functional Dyspepsia. Nutrients 2021;13:1109. [PMID: 33800668 DOI: 10.3390/nu13041109] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 15.0] [Reference Citation Analysis]
17 Sheptulin AA, Vinogradskaya KE. Gastroesophageal refl ux disease and irritable bowel syndrome overlapping: unresolved issues. jour 2021;98:645-649. [DOI: 10.30629/0023-2149-2020-98-9-10-645-649] [Reference Citation Analysis]
18 Kucheryavyy YA, Andreev DN, Maev IV. [Prevalence of small bowel bacterial overgrowth in patients with functional dyspepsia: a meta-analysis]. Ter Arkh 2020;92:53-8. [PMID: 33720574 DOI: 10.26442/00403660.2020.12.200433] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
19 Kim YS, Kim N. Functional Dyspepsia: A Narrative Review With a Focus on Sex-Gender Differences. J Neurogastroenterol Motil 2020;26:322-34. [PMID: 32606255 DOI: 10.5056/jnm20026] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 7.5] [Reference Citation Analysis]
20 Häuser W, Marschall U, Layer P, Grobe T. The Prevalence, Comorbidity, Management and Costs of Irritable Bowel Syndrome. Dtsch Arztebl Int 2019;116:463-70. [PMID: 31431234 DOI: 10.3238/arztebl.2019.0463] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
21 Andreev DN, Dicheva DT. A breach in the intestinal permeability as a factor of etiopathogenesis of functional gastrointestinal diseases. Medicinskij sovet 2020. [DOI: 10.21518/2079-701x-2020-5-87-95] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
22 Osadchuk MA, Svistunov AA, Kireeva NV, Osadchuk MM. [Functional diseases of the gastrointestinal tract in the context with overlapping functional disorders: current status of the problem]. Ter Arkh 2020;92:111-8. [PMID: 32598728 DOI: 10.26442/00403660.2020.02.000458] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
23 Brandler J, Miller LJ, Wang XJ, Burton D, Busciglio I, Arndt K, Harmsen WS, Camilleri M. Secretin effects on gastric functions, hormones and symptoms in functional dyspepsia and health: randomized crossover trial. Am J Physiol Gastrointest Liver Physiol 2020;318:G635-45. [PMID: 32036693 DOI: 10.1152/ajpgi.00371.2019] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
24 Johnson AC, Farmer AD, Ness TJ, Greenwood-Van Meerveld B. Critical evaluation of animal models of visceral pain for therapeutics development: A focus on irritable bowel syndrome. Neurogastroenterol Motil 2020;32:e13776. [PMID: 31833625 DOI: 10.1111/nmo.13776] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 4.3] [Reference Citation Analysis]
25 Lei WY, Chang WC, Wen SH, Yi CH, Liu TT, Hung JS, Wong MW, Chen CL. Predicting factors of recurrence in patients with gastroesophageal reflux disease: a prospective follow-up analysis. Therap Adv Gastroenterol. 2019;12:1756284819864549. [PMID: 31391868 DOI: 10.1177/1756284819864549] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
26 Brown BI. Does Irritable Bowel Syndrome Exist? Identifiable and Treatable Causes of Associated Symptoms Suggest It May Not. GastrointestDisord 2019;1:314-40. [DOI: 10.3390/gidisord1030027] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
27 Kountouras J, Gavalas E, Doulberis M, Polyzos SA, Papaefthymiou A, Touloumtzi M, Vardaka E, Kountouras K, Papanikolopoulou K, Katsinelos P. The Effect of Trimebutine and/or Helicobacter pylori Eradication on the Gastroesophageal Reflux Disease, Irritable Bowel Syndrome, and Functional Dyspepsia Overlapping Disorders. J Neurogastroenterol Motil 2019;25:473-4. [PMID: 31177649 DOI: 10.5056/jnm19033] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
28 Hajishafiee M, Bitarafan V, Feinle-Bisset C. Gastrointestinal Sensing of Meal-Related Signals in Humans, and Dysregulations in Eating-Related Disorders. Nutrients 2019;11:E1298. [PMID: 31181734 DOI: 10.3390/nu11061298] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 6.3] [Reference Citation Analysis]
29 de Bortoli N, Chio TD, Mariani L, Savarino EV. Authors' reply. Ann Gastroenterol 2019;32:319. [PMID: 31040634 DOI: 10.20524/aog.2019.0369] [Reference Citation Analysis]
30 Kountouras J, Doulberis M, Papaefthimiou A, Polyzos SA. Gastroesophageal reflux disease, irritable bowel syndrome and functional dyspepsia as overlapping conditions: focus on effect of trimebutine. Ann Gastroenterol 2019;32:318. [PMID: 31040633 DOI: 10.20524/aog.2019.0366] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
31 Seo HS, Choi M, Son SY, Kim MG, Han DS, Lee HH. Evidence-Based Practice Guideline for Surgical Treatment of Gastroesophageal Reflux Disease 2018. J Gastric Cancer. 2018;18:313-327. [PMID: 30607295 DOI: 10.5230/jgc.2018.18.e41] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]